Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2008
12/25/2008US20080318933 5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders
12/25/2008US20080318929 Pyrimidine Derivatives Useful as Inhibitors of Pkc-Theta
12/25/2008US20080318928 Bengamides with a substituted caprolactam cycle, method for the preparation thereof, compositions containing them and use thereof
12/25/2008US20080318923 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle
12/25/2008US20080318903 Methods for treating cancer
12/25/2008US20080318902 Triheterocyclic compounds and compositions thereof
12/25/2008US20080317744 Indole and Benzimidazole Derivatives
12/25/2008US20080317712 Arylpiperidinyl and arylpyrrolidinyl tripeptide hepatitis c serine protease inhibitors
12/24/2008WO2008157575A1 Protein kinase inhibitors and methods for using thereof
12/24/2008WO2008157537A2 Compositions and methods of use for treating or preventing lipid related disorders
12/24/2008WO2008157500A1 Aminoquinazoline cannabinoid receptor modulators for treatment of disease
12/24/2008WO2008157407A2 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia
12/24/2008WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors
12/24/2008WO2008157131A1 Protein kinase inhibitors and methods for using thereof
12/24/2008WO2008156573A1 Kinase inhibitors, compositions thereof, and methods of use therewith
12/24/2008WO2008156174A1 Pyrazinamide compound
12/24/2008WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008156092A1 Azolylmethylidenehydrazine derivative and use thereof
12/24/2008WO2008155140A1 Alkynylpyrimidines as tie2 kinase inhibitors
12/24/2008WO2008155081A2 Substituted aromatic heterocyclic compounds as fungicides
12/24/2008WO2008155022A1 Pyrrole derivatives as p2y12 antagonists
12/24/2008WO2008155001A1 Indazolamide derivatives
12/24/2008WO2008154798A1 N,n-dialkylamidophenyl-dipyrazolyl triazine photosensitive compounds, their europium complexes and their preparation methods
12/24/2008WO2008125839A3 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
12/24/2008WO2008123540A3 Organic electroluminescent device
12/24/2008WO2008121861A3 Pyrazole and pyrrole compounds useful in treating iron disorders
12/24/2008WO2008086014A3 Bis-aryl amide derivatives useful for the treatment of cancer
12/24/2008WO2008076754A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
12/24/2008WO2008076685A3 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
12/24/2008WO2008057856A3 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
12/24/2008WO2008033455A3 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
12/24/2008WO2008013840A3 Erastin analogs and uses thereof
12/24/2008WO2008009078A3 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
12/24/2008WO2008009077A3 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
12/24/2008EP2006289A1 Pyrazole-type cyanine dye
12/24/2008EP2006288A1 Aminopyridine derivative and plant disease control agent for agricultural or horticultural use
12/24/2008EP2005962A2 Therapeutic agent for inflammatory bowel disease
12/24/2008EP2004641A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
12/24/2008EP2004637A1 Substituted ring fused azines and their use in cancer therapy
12/24/2008EP2004625A2 C-met protein kinase inhibitors for the treatment of proliferative disorders
12/24/2008EP2004623A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
12/24/2008EP2004616A1 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative
12/24/2008EP2004615A2 Quinazolines for pdk1 inhibition
12/24/2008EP2004614A1 Tetrahalogenated compounds useful as inhibitors of angiogenesis
12/24/2008EP2004613A2 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators
12/24/2008EP2004601A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
12/24/2008EP1599096B1 Hetero substitued sodium channel blockers
12/24/2008EP1554274B1 1-acyl-pyrrolidine derivatives for the treatment of viral infections
12/24/2008EP1531819B1 USE OF I kappa B KINASE INHIBITORS FOR THE TREATMENT OF PAIN
12/24/2008EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
12/24/2008DE102007028521A1 Indazolamidderivate Indazolamidderivate
12/24/2008CN101331125A N-(5-membered aromatic ring)-amido anti-viral compounds
12/24/2008CN101331116A N-(6-membered aromatic ring)-amido anti-viral compounds
12/24/2008CN101331115A Derivatives for modulation of ion channels
12/24/2008CN101328167A Preparation of losartan
12/24/2008CN101328166A 2-dihydroindole ketone derivate as protein kinase inhibitor and histone deacetylase inhibitor
12/24/2008CN101328150A 新的苯并咪唑衍生物 New benzimidazole derivatives
12/24/2008CN100445294C Platinum complex and luminescent element
12/24/2008CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/24/2008CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
12/24/2008CA2692170A1 Azolylmethylidenehydrazine derivative and use thereof
12/24/2008CA2691100A1 Protein kinase inhibitors and methods for using thereof
12/24/2008CA2691019A1 Indazolamide derivatives
12/24/2008CA2690653A1 Protein kinase inhibitors and methods for using thereof
12/24/2008CA2690410A1 Kinase inhibitors, compositions thereof, and methods of use therewith
12/24/2008CA2690243A1 Pyrrole derivatives as p2y12 antagonists
12/24/2008CA2689393A1 Alkynylpyrimidines as tie2 kinase inhibitors
12/24/2008CA2688441A1 Substituted aromatic heterocyclic compounds as fungicides
12/24/2008CA2687255A1 Heteroarylamide pyrimidone derivatives
12/24/2008CA2687156A1 Arylamide pyrimidone compounds
12/24/2008CA2687151A1 Heteroarylamide pyrimidone compounds
12/23/2008US7468385 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide
12/23/2008US7468380 Nitrogen-containing aromatic derivatives
12/23/2008US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/23/2008US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression;
12/23/2008US7468212 Organic electroluminescent device
12/23/2008US7468198 Enhancing contrast; 5-alkyl or alkoxy-pyrimidinyl-phenyl-silyl-thiophenecarboxylate derivative
12/23/2008CA2560580C Imidazole compounds for inhibition of a.beta.-peptide production and for modulation of the notch signaling pathway
12/23/2008CA2448058C Pyrazole derivatives as hiv reverse transcriptase inhibitors
12/23/2008CA2442557C Dihydro-benzo¬b|¬1,4|diazepin-2-one derivatives as mglur2 antagonists ii
12/18/2008WO2008154241A1 5-heteroaryl substituted indazoles as kinase inhibitors
12/18/2008WO2008153902A2 Urotensin ii receptor antagonists
12/18/2008WO2008153870A1 Synthesis of substituted-3-aminopyrazoles
12/18/2008WO2008153858A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008WO2008153857A1 Dual-acting benzoimidazole antihypertensive agents
12/18/2008WO2008153793A2 Gamma secretase modulators
12/18/2008WO2008153752A2 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
12/18/2008WO2008153701A1 Compounds for inhibiting ksp kinesin activity
12/18/2008WO2008153091A1 Screening method
12/18/2008WO2008153042A1 Anti-tumor agent
12/18/2008WO2008152223A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/18/2008WO2008152097A1 Cinnamic acid derivatives as modulators of the ep2 receptor
12/18/2008WO2008152094A2 Substituted acetamides as modulators of the ep2 receptor
12/18/2008WO2008152093A2 Diaminopyrimidines as modulators of the ep2 receptor
12/18/2008WO2008152073A2 Piperazine compounds with a herbicidal action
12/18/2008WO2008152014A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
12/18/2008WO2008151927A2 6-n-substituted benz imidazole derivatives as acid pump antagonists
12/18/2008WO2008131103A3 Drug discovery methods for aurora kinase inhibitors
1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 626